JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1997; 30:1181-1186
© 1997 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rawles, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rawles, J.

Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT)

JM Rawles

Medicines Assessment Research Unit, University of Aberdeen, Aberdeen, Scotland, United Kingdom.

OBJECTIVES: This report presents the 5-year results of the Grampian Region Early Anistreplase Trial (GREAT) and quantifies the benefit of earlier thrombolysis in terms that are generally applicable. BACKGROUND: Although it is accepted that the earlier thrombolytic therapy is given for acute myocardial infarction the greater the benefit, there are widely differing estimates of the magnitude of the time-related benefit of thrombolysis because of inappropriate trial design and analysis. METHODS: In a previously reported randomized trial, anistreplase (30 U) was given intravenously either before hospital admission or in the hospital, at a median time of 105 and 240 min, respectively, after onset of symptoms. Intention to treat and multivariate analyses of the 5-year results were performed. RESULTS: By 5 years, 41 (25%) of 163 patients had died in the prehospital treatment group compared with 53 (36%) of 148 in the hospital treatment group (log-rank test, p < 0.025). Delaying thrombolytic treatment by 1 h increases the hazard ratio of death by 20%, equivalent to the loss of 43/1,000 lives within the next 5 years (95% confidence interval 7 to 88, p = 0.012). Delaying thrombolytic treatment by 30 min reduces the average expectation of life by approximately 1 year. CONCLUSIONS: The magnitude of the benefit from earlier thrombolysis is such that giving thrombolytic therapy to patients with acute myocardial infarction should be accorded the same degree of urgency as treatment of cardiac arrest. Policies should be developed for giving thrombolytic therapy on-site if practicable and by the first qualified person to see the patient.


This article has been cited by other articles:


Home page
Emerg. Med. J.Home page
P Gilligan, S Winder, I Singh, V Gupta, P O Kelly, and D Hegarty
The Boarders in the Emergency Department (BED) study
Emerg. Med. J., May 1, 2008; 25(5): 265 - 269.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P G Steg, J-P Cambou, P Goldstein, E Durand, P Sauval, Z Kadri, D Blanchard, J-M Lablanche, P Gueret, Y Cottin, et al.
Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry
Heart, October 1, 2006; 92(10): 1378 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
D Gray
Thrombolysis: past, present, and future.
Postgrad. Med. J., June 1, 2006; 82(968): 372 - 375.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 8: Stabilization of the Patient With Acute Coronary Syndromes
Circulation, December 13, 2005; 112(24_suppl): IV-89 - IV-110.
[Full Text] [PDF]


Home page
Emerg. Med. J.Home page
M Woollard, K Pitt, A J Hayward, and N C Taylor
Limited benefits of ambulance telemetry in delivering early thrombolysis: a randomised controlled trial
Emerg. Med. J., March 1, 2005; 22(3): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A.J. Adgey, H.R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Makijarvi, et al.
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction
Circulation, July 15, 2003; 108(2): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. K Pedley, K. Bissett, E. M Connolly, C. G Goodman, I. Golding, T H Pringle, G P McNeill, S D Pringle, and M C Jones
Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics
BMJ, July 3, 2003; 327(7405): 22 - 26.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Kukulski, F. Jamal, L. Herbots, J. D'hooge, B. Bijnens, L. Hatle, I. De Scheerder, and G. R. Sutherland
Identification of acutely ischemic myocardium using ultrasonic strain measurements: A clinical study in patients undergoing coronary angioplasty
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 810 - 819.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. J. Schull, L. J. Morrison, M. Vermeulen, and D. A. Redelmeier
Emergency department overcrowding and ambulance transport delays for patients with chest pain
Can. Med. Assoc. J., February 4, 2003; 168(3): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Widimsky, T. Budesinsky, D. Vorac, L. Groch, M. Zelizko, M. Aschermann, M. Branny, J. St'asek, P. Formanek, and on behalf of the 'PRAGUE' Study Group Investigator
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial--PRAGUE-2
Eur. Heart J., January 1, 2003; 24(1): 94 - 104.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
D T Stephenson, J W Wardrope, and S W Goodacre
Is prehospital thrombolysis for acute myocardial infarction warranted in the urban setting? The case against
Emerg. Med. J., September 1, 2002; 19(5): 444 - 447.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E.M. Antman, H.A. Cooper, C.M. Gibson, J.A. de Lemos, C.H. McCabe, R.P. Giugliano, P. Coussement, S. Murphy, J. Scherer, K. Anderson, et al.
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II
Eur. Heart J., June 2, 2002; 23(12): 928 - 933.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
K Pitt
Prehospital selection of patients for thrombolysis by paramedics
Emerg. Med. J., May 1, 2002; 19(3): 260 - 263.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. W. Stone, D. Cox, E. Garcia, B. R. Brodie, M.-C. Morice, J. Griffin, L. Mattos, A. J. Lansky, W. W. O'Neill, and C. L. Grines
Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials
Circulation, August 7, 2001; 104(6): 636 - 641.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W. J PENNY
Patient delay in calling for help: the weakest link in the chain of survival?
Heart, February 1, 2001; 85(2): 121 - 122.
[Full Text]


Home page
HeartHome page
W S Leslie, A Urie, J Hooper, and C E Morrison
Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care
Heart, August 1, 2000; 84(2): 137 - 141.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C T Hourigan, D Mountain, P E Langton, I G Jacobs, I R Rogers, G A Jelinek, and P L Thompson
Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time
Heart, August 1, 2000; 84(2): 157 - 163.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Widimsky, L. Groch, M. Zelizko, M. Aschermann, F. Bednar, and H. Suryapranata
Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study
Eur. Heart J., May 2, 2000; 21(10): 823 - 831.
[Abstract] [PDF]


Home page
NEJMHome page
E. Boersma, M. Akkerhuis, M. L. Simoons, F. Zijlstra, M.-J. de Boer, D. P. Faxon, and J. W. Heger
Primary Angioplasty versus Thrombolysis for Acute Myocardial Infarction
N. Engl. J. Med., March 23, 2000; 342(12): 890 - 892.
[Full Text]


Home page
J Am Coll CardiolHome page
G. A. Ewy and J. P. Ornato
Emergency cardiac care: introduction
J. Am. Coll. Cardiol., March 15, 2000; 35(4): 825 - 880.
[Full Text] [PDF]


Home page
CirculationHome page
J. Rawles, C. F. Lundergan, and A. M. Ross
Extended Mortality Benefit of Early Postinfarction Reperfusion • Response
Circulation, December 22, 1998; 98 (25): 2932 - 2935.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. R. Brodie, T. D. Stuckey, T. C. Wall, G. Kissling, C. J. Hansen, D. B. Muncy, R. A. Weintraub, and T. A. Kelly
Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1312 - 1319.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Rawles, C. Sinclair, K. Jennings, L. Ritchie, and N. Waugh
Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study
BMJ, August 29, 1998; 317(7158): 576 - 578.
[Abstract] [Full Text]


Home page
JWatch Emergency Med.Home page
Does Prehospital Thrombolysis Reduce Long-Term MI Deaths?
Journal Watch Emergency Medicine, January 1, 1998; 1998(101): 3 - 3.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1997 by the American College of Cardiology Foundation.